Title:
膵臓がんおよびその他のがんに対する免疫療法において使用するための新規ペプチドおよびペプチドの組み合わせ
Document Type and Number:
Japanese Patent JP6990935
Kind Code:
B2
Abstract:
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
Inventors:
Weinschenk, Toni
Fritche, jens
Shin, Harpreet
Andrea, Mare
Otto, Martina
Wagner, Claudia
Shall, Oliver
Fritche, jens
Shin, Harpreet
Andrea, Mare
Otto, Martina
Wagner, Claudia
Shall, Oliver
Application Number:
JP2020047156A
Publication Date:
February 15, 2022
Filing Date:
March 18, 2020
Export Citation:
Assignee:
Immatics Biotechnology Gem Beher
International Classes:
C07K7/06; A61K35/17; A61K35/76; A61K38/08; A61K39/395; A61K48/00; A61P35/00; A61P35/02; C07K16/18; C07K16/28; C12N5/0783; C12N5/0784; C12N5/10; C12N15/115; C12N15/12; C12N15/13; C12N15/62; C12N15/63; C12P21/02
Domestic Patent References:
| JP2010534463A | ||||
| JP2013521789A |
Other References:
Blood,2003年,vol.101, no.7,p.2704-2710
Attorney, Agent or Firm:
Takashi Shoji